维普期刊资源整合服务平台（V6.5）

71篇 您的检索式：作者名="STROOBANT P"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated withhigh-dose chemotherapy and stem cell transplantation显示文摘	Spaepen K Stroobants S Dupont P		Bl0，，：	1
2	Early restaging pos- itron emission tomography with (18) F-fluorodeoxyglucose predicts outcome in patients with aggressive non-HodgkinTs lymphoma显示文摘	Spaepen K Stroobants S Dupont P	2002	Ann Oncol2002，13，9：	1
3	Prognostic value of pretrans- plantation positron emission tomography using fluorine 18-fluorodeox- yglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation显示文摘	Spaepen K Stroobants S Dupont P	2003	Blood2003，102，1：	1
4	Prospective comparative study of integrated positron emission tomography-computed tomography scan compared with remediastinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinoscopy-proven stage IIIA-N2 non-small-cell lung cancer:, a Leuven Lung Cancer Group Study 显示文摘	De Leyn P Stroobants S De Wever W	2006	J Clin Oneol2006，24，21：	1
5	Can positron emis- sion tomography with -fluorodeoxyglucose after first- line treatment distinguish Hodgkin' s disease patients who need additional therapy from others in whom additional thera- py would mean avoidable toxicity? 显示文摘	Spaepen K Stroobants S Dupont P	2001	Br J Haematol2001，115，2：	1
6	Early restaging positron emission tomography with(18)Ffluorodeoxy glucose predicts outcome in patients with aggressive non-Hodgkin’s lymphoma显示文摘	Spaepen K Stroobants S Dupont P	2002	Ann Oncol2002，13，9：	1
7	Identification of MAGE-3 Epitopes presented by HLA-DR molecules to CD4+ T lymphocytes显示文摘	Chaux P Vantomme V Stroobant V	1999	J Exp Med1999，185，5：	1
8	Additional value of whole-body positron emission tomography with fluorine-18-2-fluoro-2-deoxy-D-glocose in recurrent colorectal cancer显示文摘		1999	Journal of Clinical Oncology1999，17，：	1
9	Can positron emission tomography with -fluorodeoxyglucose after first-line treatment distinguish Hodgkin's disease patients who need addi- tional therapy from others in whom additional therapy would mean avoidable toxicity显示文摘	Spaepen K Stroobants S Dupont P	2001	Br J Haematol2001，115，2：	1
10	A MAGE-3 peptide presented by HLA-DR1 to CD4+ T cells that were isolated from a melanoma patient vaccinated with a MAGE-3 protein显示文摘	Chaux P Stroobant V	2003	J Immunol2003，171，1：	1
11	Early restaging positron emission tomography with (18) F-fluorodeoxyglucose predicts outcome in patients with aggressive non-Hodgkin's lymphoma显示文摘	Spaepen K Stroobants S Dupont P	2002	Ann Oneol2002，13，9：	1
12	Identification of MAGE-3 epitopes presented by HLA-DR molecules to CD4(+) T lymphocytes显示文摘	Chaux P Vantomme Stroobant V	1999	JExp Med1999，189，5：	1
13	Prospective comparative study of integrated positron emission tomo-graphy - computed tomography scan compared with remedi- astinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinos- copy- proven stage In A- N2 nonsmall -cell lung cancer: a Leuven Lung Cancer Group Study 显示文摘	De Leyn P Stroobants S De Wever W	2006	J Clin Oncol2006，24，21：	1
14	Prospective comparative study of integrated positron emission tomo- graphy - computed tomography scan compared with remedi- astinoscopy in the assessment of residual mediastinal lymph node disease after induction chemotherapy for mediastinos- copy - proven stage IIIA - N2 nonsmaU - cell lung cancer: a Leuven Lung Cancer Group Study 显示文摘	De Leyn P Stroobants S De W ever W	2006	J Clin Oncol2006，24，21：	1
15	(18) FDG PETmonitoring of tumour response to chemotherapy:does FDGuptake correlate with the viable tumour cell fraction?显示文摘	Spaepen K Stroobants S Dupont P	2003	Eur J NuclMed Mol Imaging2003，30，5：	1
16	Early restaging positronemission tomography with (18)F-fluorodeoxyglucose predictsoutcome in patients with aggressive non-Hodgkin's lymphoma显示文摘	Spaepen K Stroobants S Dupont P	2002	Ann Oncol2002，13，9：	1
17	Transforming growth factortorB1 and B2 are mitogens for rat Schwann cells显示文摘	Ridley AJ Davis JB Stroobant P	1989	J Cell Biol1989，，：	1
18	Prognostic value of pretransplantation positron emission tomography using fluorine 18-fluorodeoxyglucose in patients with aggressive lymphoma treated with high-dose chemotherapy and stem cell transplantation显示文摘	Spaepen K Stroobants S Dupont P	2003	Blood2003，102，1：	1
19	FDG PET monitoring of tumour response to chemotherapy: Does FDG uptake correlate with the viable turnout cell fraction显示文摘	Spaepen K Stroobants S Dupont P	2003	Eur J Nucl Med Mol Imaging2003，30，9：	1
20	Transfor-ming growth factors-beta 1 and beta 2 are mitogens for rat Schwann cells显示文摘	RIDLEY A J DAVIS J B STROOBANT P	1989	The Journal of Cell Biology1989，109，62：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示